Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).

Battipaglia, Giorgia

Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). [electronic resource] - Annals of hematology Aug 2012 - 1327-8 p. digital

Publication Type: Case Reports; Letter

1432-0584

10.1007/s00277-011-1398-6 doi


Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Etoposide--administration & dosage
Female
Humans
Induction Chemotherapy--adverse effects
Leukemia, Myeloid, Acute--drug therapy
Middle Aged
Posterior Leukoencephalopathy Syndrome--chemically induced
Young Adult